Drug discovery inspired by bioactive small molecules from nature
- PMID: 36605590
- PMCID: PMC9809404
- DOI: 10.1080/19768354.2022.2157480
Drug discovery inspired by bioactive small molecules from nature
Abstract
Natural products (NPs) have greatly contributed to the development of novel treatments for human diseases such as cancer, metabolic disorders, and infections. Compared to synthetic chemical compounds, primary and secondary metabolites from medicinal plants, fungi, microorganisms, and our bodies are promising resources with immense chemical diversity and favorable properties for drug development. In addition to the well-validated significance of secondary metabolites, endogenous small molecules derived from central metabolism and signaling events have shown great potential as drug candidates due to their unique metabolite-protein interactions. In this short review, we highlight the values of NPs, discuss recent scientific and technological advances including metabolomics tools, chemoproteomics approaches, and artificial intelligence-based computation platforms, and explore potential strategies to overcome the current challenges in NP-driven drug discovery.
Keywords: Natural product; cell signaling; drug discovery; metabolite; metabolomics.
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures
References
-
- Austin C, Stewart D, Allwood JW, McDougall GJ.. 2018. Extracts from the edible seaweed, Ascophyllum nodosum, inhibit lipase activity in vitro: contributions of phenolic and polysaccharide components. Food Funct. 9(1):502–510. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous